IL6 and amelogenesis imperfecta type 1G: Our cell-to-cell prediction analysis utilizing scRNA-seqdata indicated that, in ERS patients, B cell-derived IL-6, T cell-derived CSF1(M-CSF), and CSF2 (GM-CSF) may promote monocyte proliferation and activation.